QUEST DIAGNOSTICS INC 4

SVP & Chief Commercial Officer Mark E. Delaney received an RSU award of 34 Quest Diagnostics Inc. (DGX) common shares.

On July 22, 2026, Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics Inc., received an award of 34 shares of common stock in the form of restricted share units at a reported value of approximately $206.81 per share, and his direct beneficial ownership following the transaction was 11,935 shares. The Form 4 notes that some shares were acquired through a dividend reinvestment plan eligible for deferred reporting on Form 5, which the reporting person chose to disclose early. Using the provided price context, the RSU award is worth roughly $7,031, and Delaney’s total direct holdings are valued at approximately $2.75 million based on the current stock price.

Filing Facts

CIK

1022079

Ticker

DGX

Form

4

Source Type

sec

Accession

0001022079-26-000079

Alert Tier

6